# Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer

> **NCT01737151** · NA · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 19 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Stage I Prostate Cancer

## Interventions

- **RADIATION:** stereotactic body radiation therapy
- **RADIATION:** four fraction split-course SBRT

## Key facts

- **NCT ID:** NCT01737151
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03-08
- **Primary completion:** 2017-11-09
- **Final completion:** 2017-11-09
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737151, "Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01737151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*